Table 5: The correlation between the change of second-phase insulin secretion before and after treatment (δ-SPIS) with various factors
a | Partial correlation coefficient | p value |
Age | -0.5963 | 0.001 |
Body mass index (kg/m2) | -0.4045 | 0.045 |
Waist circumference (cm) | -0.4385 | 0.028 |
Hip circumference (cm) | -0.3549 | 0.082 |
Waist-hip ratio | -0.1857 | 0.374 |
Systolic blood pressure (mmHg) | 0.0835 | 0.691 |
Diastolic blood pressure (mmHg) | 0.0310 | 0.883 |
Fasting plasma glucose (mg/dl) | 0.2564 | 0.216 |
Fasting plasma insulin (pmol/l) | -0.2074 | 0.320 |
Hemoglobin A1c (%) | 0.5288 | 0.008 |
δA1C | -0.4967 | 0.043 |
Total Cholesterol (mmol/l) | -0.2025 | 0.332 |
Triglyceride (mmol/l) | 0.5494 | 0.004 |
HDL-C (mmol/l) | 0.0729 | 0.729 |
First-phase insulin secretionb | -0.1158 | 0.582 |
Second-phase insulin secretionc | -0.4040 | 0.045 |
Insulin sensitivity | -0.1509 | 0.472 |
Glucose effectiveness | 0.1627 | 0.437 |
HOMA-IR | 0.0442 | 0.834 |
HOMA-B | -0.3660 | 0.072 |